Biopharma Leaders Navigate AI ‘Hype Cycle’: Bayer, Daiichi Sankyo, and argenx Share Insights on AI Implementation in Marketing

AI Adoption in Biopharma:
Bayer, Daiichi Sankyo, and argenx are actively integrating AI into their marketing strategies to leverage its potential in accelerating product development and enhancing marketing efforts.

Daiichi Sankyo's AI Initiative:
Daiichi Sankyo has developed an in-house generative AI system, DS-GAI, which has seen rapid adoption among its employees, improving work efficiency and output quality.

Bayer's AI Transformation:
Bayer is harnessing AI to transform health and nutrition by catalyzing faster product development and leveraging cutting-edge AI technologies.

Industry Perspective:
The biopharma industry is cautiously navigating the AI 'hype cycle', focusing on practical applications and tangible benefits rather than getting caught up in the hype.

AI's Role in Marketing:
AI is being used to develop ideas, assist with coding and content creation, and contribute to learning and data analysis, enhancing the overall organizational culture and digital transformation.